OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 102,658 results

Filters: Cost effectiveness analysis

The relationship between cost-effectiveness analysis and cost-benefit analysis.
M Johannesson
Soc Sci Med. Aug, 1995.41(4):483-9 Print
Source:PubMed
PMID: 7481942 doi:10.1016/0277-9536(94)00353-u
Cost-effectiveness analysis in radiology.
M E Singer, K E Applegate
Radiology. Jun, 2001.219(3):611-20 Print
Source:PubMed
PMID: 11376244 doi:10.1148/radiology.219.3.r01jn04611
Cost-effectiveness analysis in surgery.
S R Finlayson, J D Birkmeyer
Surgery. Feb, 1998.123(2):151-6 Print
Source:PubMed
PMID: 9481400 doi:
Understanding cost effectiveness in neurology.
Iván Sánchez Fernández
J Neurol Sci. 12 15, 2023.455:122787 Print-Electronic
Source:PubMed
PMID: 37979414 doi:10.1016/j.jns.2023.122787
Cost-effectiveness analysis in pathology.
S S Raab
Clin Lab Med. Dec, 1999.19(4):757-71, v-vi Print
Source:PubMed
PMID: 10572713 doi:
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.
Tobias Gerhard, Issam Zineh, Almut G Winterstein, Abraham G Hartzema
Pharmacotherapy. Jan, 2006.26(1):34-43 Print
Source:PubMed
PMID: 16509026 doi:10.1592/phco.2006.26.1.34
The decision rules of cost-effectiveness analysis.
G Karlsson, M Johannesson
Pharmacoeconomics. Feb, 1996.9(2):113-20 Print
Source:PubMed
PMID: 10160090 doi:10.2165/00019053-199609020-00003
Cost-effectiveness analysis and insurance coverage: solving a puzzle.
Mark Pauly
Health Econ. May, 2015.24(5):506-15 Print-Electronic
Source:PubMed
PMID: 24677289 doi:10.1002/hec.3044
Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.
Kiran Bambha, W Ray Kim
Eur J Gastroenterol Hepatol. Jun, 2004.16(6):519-26 Print
Source:PubMed
PMID: 15167152 doi:10.1097/00042737-200406000-00003
[Cost-effectiveness analysis in the treatment of hematologic malignancies].
Chihiro Yamamoto
Rinsho Ketsueki. 2024.65(9):1190-1198 Print
Source:PubMed
PMID: 39358277 doi:10.11406/rinketsu.65.1190
0